# EXO1

## Overview
Exonuclease 1 (EXO1) is a gene that encodes a protein of the same name, which plays a pivotal role in DNA repair and replication processes. The EXO1 protein is categorized as a 5' to 3' exonuclease, essential for maintaining genomic stability through its involvement in various DNA repair pathways, including mismatch repair (MMR), homologous recombination (HR), and double-strand break repair (DSBR) (Keijzers2016Exonuclease; Keijzers2018Human). The protein's structure, characterized by a conserved nuclease domain, facilitates its enzymatic activity and interactions with other proteins involved in DNA repair (Yan2021Multifunctions). EXO1 is subject to post-translational modifications that regulate its function and interactions, highlighting its dynamic role in cellular processes (Sertic2020EXO1:). Clinically, mutations and altered expression of the EXO1 gene have been linked to increased cancer susceptibility, particularly in hereditary nonpolyposis colorectal cancer (HNPCC) and other malignancies, underscoring its significance in cancer biology (Pezeshki2023Investigating; Wu2001Germline).

## Structure
Exonuclease 1 (EXO1) is a protein encoded by the human EXO1 gene, characterized by a distinct molecular structure that facilitates its role in DNA repair processes. The primary structure of EXO1 consists of 846 amino acids, forming a polypeptide chain with specific functional domains (Yan2021Multifunctions). The N-terminal region of EXO1 contains a conserved nuclease domain responsible for its 5' to 3' exonuclease activity, crucial for DNA mismatch repair and other repair pathways (Sertic2020EXO1:; Keijzers2016Exonuclease).

The secondary structure of EXO1 includes alpha helices and beta sheets, contributing to the formation of its catalytic core. The tertiary structure involves the folding of these elements into a three-dimensional conformation, with the N-terminal domain forming a catalytic core and the C-terminal region being more flexible and involved in protein-protein interactions (Goellner2015Exonuclease; Yan2021Multifunctions).

EXO1 also undergoes various post-translational modifications, such as phosphorylation, ubiquitination, and SUMOylation, which regulate its activity and interactions with other proteins (Sertic2020EXO1:; Yan2021Multifunctions). The protein exists in two isoforms, EXO1a and EXO1b, resulting from alternative splicing, with EXO1b being the full-length version (Sertic2020EXO1:; Keijzers2016Exonuclease). These structural features and modifications are essential for EXO1's function in maintaining genomic integrity.

## Function
Exonuclease 1 (EXO1) is a crucial enzyme in DNA repair and replication processes in human cells. It functions as a 5' to 3' exonuclease and is involved in several DNA repair pathways, including mismatch repair (MMR), homologous recombination (HR), and double-strand break repair (DSBR) (Keijzers2016Exonuclease; Keijzers2018Human). In MMR, EXO1 interacts with proteins such as MLH1, MSH2, and MSH3 to excise mismatched bases from newly synthesized DNA strands, ensuring genomic stability (Shao2014Hydrolytic; Keijzers2016Exonuclease). 

EXO1 also plays a significant role in HR by resecting DNA ends to produce single-stranded overhangs necessary for repair, interacting with the MRE11-RAD50-NBS1 complex and other proteins involved in DNA damage response (Keijzers2018Human). It is active in the nucleus, where it maintains replication fork stability and participates in post-replicative repair processes (Keijzers2018Human). 

EXO1's activity is essential for safeguarding genome stability, preventing mutations, and contributing to telomere maintenance, although its role in telomere dynamics is not fully understood (Keijzers2016Exonuclease). Its involvement in these processes underscores its importance in maintaining chromosomal integrity and preventing tumorigenesis (Keijzers2016Exonuclease).

## Clinical Significance
Mutations and alterations in the EXO1 gene have been implicated in various diseases, particularly cancer. Germline mutations in EXO1 have been associated with hereditary nonpolyposis colorectal cancer (HNPCC) and atypical forms of HNPCC. These mutations include splice-site and missense mutations, which can lead to microsatellite instability in tumors, a hallmark of HNPCC-related cancers (Wu2001Germline). However, the role of EXO1 in cancer predisposition remains unclear, as some variants are also found in normal individuals, suggesting that germline mutations in EXO1 are a rare cause of HNPCC (Wei2003Inactivation).

In mice, inactivation of Exo1 results in increased cancer susceptibility, particularly lymphomas, due to defects in DNA mismatch repair (Wei2003Inactivation). In humans, specific single nucleotide polymorphisms (SNPs) in EXO1, such as rs1047840, have been linked to an increased risk of various cancers, including lung, colorectal, and breast cancers (Pezeshki2023Investigating).

Altered expression of EXO1 is also associated with aggressive prostate cancer. High EXO1 expression correlates with poor survival outcomes and is considered an independent risk factor for metastasis and mortality in prostate cancer patients (Luo2019Exonuclease). These findings underscore the clinical significance of EXO1 in cancer development and progression.

## Interactions
EXO1 interacts with several proteins and complexes involved in DNA repair processes. It forms a constitutive complex with the MutLγ complex, specifically interacting with Mlh1 and Mlh3, which are crucial for meiotic crossover formation (Sanchez2020Exo1). EXO1 also interacts with the Cdc5 polo kinase, serving as a recruiting and activating platform for Cdc5, which in turn activates the MutLγ complex (Sanchez2020Exo1). This interaction is mediated through a specific motif in EXO1, and mutations in this motif can significantly reduce the interaction, affecting crossover formation (Sanchez2020Exo1).

In the context of mismatch repair (MMR), EXO1 interacts with Msh2 through two conserved sequence motifs known as SHIP boxes located in its C-terminal tail. These interactions are essential for EXO1-dependent MMR, as mutations in these motifs disrupt the binding to Msh2 (Goellner2018Identification). EXO1 also interacts with MutSα, which stimulates EXO1-dependent excision in MMR (Sertic2020EXO1:).

EXO1's activity is regulated by interactions with proteins such as MutLα and CtIP, which can inhibit its activity, potentially by inducing conformational changes (Sertic2020EXO1:). It also interacts with 14-3-3 proteins, which are involved in its subnuclear localization and regulation at double-strand breaks and stalled replication forks (Sertic2020EXO1:).


## References


[1. (Luo2019Exonuclease) Fei Luo, Yu‐Zhuo Wang, Dong Lin, Jian Li, and Kuo Yang. Exonuclease 1 expression is associated with clinical progression, metastasis, and survival prognosis of prostate cancer. Journal of Cellular Biochemistry, 120(7):11383–11389, February 2019. URL: http://dx.doi.org/10.1002/jcb.28415, doi:10.1002/jcb.28415. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcb.28415)

[2. (Pezeshki2023Investigating) Milad Pezeshki, Sayed Mostafa Hosseini, Jamshid Ansari, and Azam Ahmadi. Investigating the importance of egfr (− 216g/t), exo1 (k589e) and lep (− 2548g/a) gene polymorphisms with risk of lung cancer as potential diagnostic biomarker in iranian population. Egyptian Journal of Medical Human Genetics, September 2023. URL: http://dx.doi.org/10.1186/s43042-023-00436-8, doi:10.1186/s43042-023-00436-8. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s43042-023-00436-8)

[3. (Wu2001Germline) Ying Wu, Rob G.J. Mensink, Edwin Verlind, Rolf H. Sijmons, Charles H.C.M. Buys, Robert M.W. Hofstra, Maran J.W. Berends, Jan H. Kleibeuker, Jan G. Post, Claudia Kempinga, Tineke van der Sluis, Harry Hollema, and Ate G.J. van der Zee. Germline mutations of exo1 gene in patients with hereditary nonpolyposis colorectal cancer (hnpcc) and atypical hnpcc forms. Gastroenterology, 120(7):1580–1587, June 2001. URL: http://dx.doi.org/10.1053/gast.2001.25117, doi:10.1053/gast.2001.25117. This article has 190 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1053/gast.2001.25117)

[4. (Keijzers2016Exonuclease) Guido Keijzers, Dekang Liu, and Lene Juel Rasmussen. Exonuclease 1 and its versatile roles in dna repair. Critical Reviews in Biochemistry and Molecular Biology, 51(6):440–451, August 2016. URL: http://dx.doi.org/10.1080/10409238.2016.1215407, doi:10.1080/10409238.2016.1215407. This article has 66 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/10409238.2016.1215407)

[5. (Wei2003Inactivation) Kaichun Wei, Alan B. Clark, Edmund Wong, Michael F. Kane, Dan J. Mazur, Tchaiko Parris, Nadine K. Kolas, Robert Russell, Harry Hou, Burkhard Kneitz, Guohze Yang, Thomas A. Kunkel, Richard D. Kolodner, Paula E. Cohen, and Winfried Edelmann. Inactivation of exonuclease 1 in mice results in dna mismatch repair defects, increased cancer susceptibility, and male and female sterility. Genes &amp; Development, 17(5):603–614, February 2003. URL: http://dx.doi.org/10.1101/gad.1060603, doi:10.1101/gad.1060603. This article has 261 citations.](https://doi.org/10.1101/gad.1060603)

[6. (Goellner2018Identification) Eva M. Goellner, Christopher D. Putnam, William J. Graham, Christine M. Rahal, Bin-Zhong Li, and Richard D. Kolodner. Identification of exo1-msh2 interaction motifs in dna mismatch repair and new msh2-binding partners. Nature Structural &amp; Molecular Biology, 25(8):650–659, July 2018. URL: http://dx.doi.org/10.1038/s41594-018-0092-y, doi:10.1038/s41594-018-0092-y. This article has 34 citations.](https://doi.org/10.1038/s41594-018-0092-y)

[7. (Keijzers2018Human) Guido Keijzers, Daniela Bakula, Michael Angelo Petr, Nils Gedsig Kirkelund Madsen, Amanuel Teklu, Garik Mkrtchyan, Brenna Osborne, and Morten Scheibye-Knudsen. Human exonuclease 1 (exo1) regulatory functions in dna replication with putative roles in cancer. International Journal of Molecular Sciences, 20(1):74, December 2018. URL: http://dx.doi.org/10.3390/ijms20010074, doi:10.3390/ijms20010074. This article has 57 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms20010074)

[8. (Goellner2015Exonuclease) Eva M. Goellner, Christopher D. Putnam, and Richard D. Kolodner. Exonuclease 1-dependent and independent mismatch repair. DNA Repair, 32:24–32, August 2015. URL: http://dx.doi.org/10.1016/j.dnarep.2015.04.010, doi:10.1016/j.dnarep.2015.04.010. This article has 115 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.dnarep.2015.04.010)

[9. (Shao2014Hydrolytic) H. Shao, C. Baitinger, E. J. Soderblom, V. Burdett, and P. Modrich. Hydrolytic function of exo1 in mammalian mismatch repair. Nucleic Acids Research, 42(11):7104–7112, May 2014. URL: http://dx.doi.org/10.1093/nar/gku420, doi:10.1093/nar/gku420. This article has 27 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gku420)

[10. (Sanchez2020Exo1) Aurore Sanchez, Céline Adam, Felix Rauh, Yann Duroc, Lepakshi Ranjha, Bérangère Lombard, Xiaojing Mu, Mélody Wintrebert, Damarys Loew, Alba Guarné, Stefano Gnan, Chun-Long Chen, Scott Keeney, Petr Cejka, Raphaël Guérois, Franz Klein, Jean-Baptiste Charbonnier, and Valérie Borde. Exo1 recruits cdc5 polo kinase to mutlγ to ensure efficient meiotic crossover formation. Proceedings of the National Academy of Sciences, 117(48):30577–30588, November 2020. URL: http://dx.doi.org/10.1073/pnas.2013012117, doi:10.1073/pnas.2013012117. This article has 33 citations.](https://doi.org/10.1073/pnas.2013012117)

[11. (Yan2021Multifunctions) Shuang Yan, Shanshan Gao, and Pingkun Zhou. Multi-functions of exonuclease 1 in dna damage response and cancer susceptibility. Radiation Medicine and Protection, 2(4):146–154, December 2021. URL: http://dx.doi.org/10.1016/j.radmp.2021.08.004, doi:10.1016/j.radmp.2021.08.004. This article has 4 citations.](https://doi.org/10.1016/j.radmp.2021.08.004)

[12. (Sertic2020EXO1:) Sarah Sertic, Roberto Quadri, Federico Lazzaro, and Marco Muzi-Falconi. Exo1: a tightly regulated nuclease. DNA Repair, 93:102929, September 2020. URL: http://dx.doi.org/10.1016/j.dnarep.2020.102929, doi:10.1016/j.dnarep.2020.102929. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.dnarep.2020.102929)